Find therapies in clinical trials near you – page 59

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer

Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Study on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis

Study on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis

Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease

Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease

Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

Study of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer

Study of Glofitamab, Atezolizumab, and Polatuzumab Vedotin for Adults with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma